LEP and breast carcinoma: The circulating levels of adipokines like leptin and adiponectin have been suggested as potential markers of increased risk for developing cardiovascular disorders ( 21 ) and breast cancer ( 22 ) but their potential role in the pathogenesis of these disorders remains obscure.